Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
CSL Limited
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== A/H1N1 2009 pandemic === {{See also|2009 swine flu pandemic in Australia}} CSL's vaccine for [[Influenza A virus subtype H1N1|swine flu]], the world's first, was approved in September 2009 for use by people over age 10.<ref>{{cite web |title=Panvax H1N1 Approval For Registration For Use in Australia by Therapeutic Goods Administration |url=http://www.csl.com.au/s1/cs/auhq/1196562649899/news/1249870443804/prdetail.htm |archive-url=https://web.archive.org/web/20090925175938/http://www.csl.com.au/s1/cs/auhq/1187378853299/news/1249870443804/prdetail.htm |publisher=CSL Limited |location=Melbourne, Australia |date=18 September 2009 |archive-date=25 September 2009 |access-date=26 September 2009 |quote=CSL Biotherapies, a subsidiary of CSL Limited, Australia's leading biopharmaceutical company, can today confirm that its vaccine against the pandemic (H1N1) 2009 influenza or 'swine flu' has been approved registration for use in people aged 10 years and over. |url-status=live }}</ref> The federal government ordered 21{{nbsp}}million doses of vaccine for Australians.<ref>{{Cite news|last=Tran|first=Mark|date=2009-07-22|title=First human trials of swine flu vaccine begin in Australia|language=en-GB|work=The Guardian|url=https://www.theguardian.com/world/2009/jul/22/swine-flu-australia-vaccine-tests|access-date=2020-09-07|issn=0261-3077}}</ref> [[CSL Behring|CSL]] also provided vaccines for customers in Singapore and the US. On 28 September 2010, the Australian [[Therapeutic Goods Administration]] (TGA) conducted an analysis of [[febrile convulsions]] following immunisation in children following monovalent pandemic [[Influenza A virus subtype H1N1|H1N1]] vaccine (Panvax/Panvax Junior, CSL).<ref>{{Cite web |last=Administration |first=Australian Government Department of Health Therapeutic Goods |date=2010-09-28 |title=Analysis of febrile convulsions following immunisation in children following monovalent pandemic H1N1 vaccine (Panvax/Panvax Junior, CSL) |url=https://www.tga.gov.au/alert/analysis-febrile-convulsions-following-immunisation-children-following-monovalent-pandemic-h1n1-vaccine-panvaxpanvax-junior-csl |access-date=2022-07-25 |website=Therapeutic Goods Administration (TGA) |language=en}}</ref> A paper published in the Medical Journal of Australia provides a possible reason for CSL's 2010 flu vaccine causing febrile convulsions in children. The authors hypothesise that suboptimal use of the detergent called [[deoxycholate]] β used in the manufacturing process by CSL (one of the few vaccine manufacturers that use it) β to split the flu virus from its membrane may be at fault.<ref>{{cite journal|title=Adverse events associated with 2010 CSL and other inactivated influenza vaccines|pmid=21929484|doi=10.5694/mja11.10941|journal=The Medical Journal of Australia|volume=195|issue=6|date=19 September 2011|pages=318β320|first1=Heath A|last1=Kelly|first2=Danuta M|last2=Skowronski|first3=Gaston|last3=De Serres|first4=Paul V|last4=Effler|s2cid=9389146 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)